Comparison of long-term mortality risk following normal exercise vs adenosine myocardial perfusion SPECT

A higher frequency of clinical events has been observed in patients undergoing pharmacological vs exercise myocardial perfusion single-photon emission computed tomography (SPECT). While this difference is attributed to greater age and co-morbidities, it is not known whether these tests also differ in prognostic ability among patients with similar clinical profiles. We assessed all-cause mortality rates in 6,069 patients, followed for 10.2 ± 1.7 years after undergoing exercise or adenosine SPECT. We employed propensity analysis to match exercise and adenosine subgroups by age, gender, symptoms, and coronary risk factors. Within our propensity-matched cohorts, adenosine patients had an annualized mortality rate event rates that was more than twice that of exercise patients (3.9% vs 1.6%, P < .0001). Differences in mortality persisted among age groups, including those <55 years old. In the exercise cohort, mortality was inversely related to exercise duration, with comparable mortality noted for patients exercising <3 min and those undergoing adenosine testing. Among patients with normal stress SPECT tests, those undergoing adenosine testing manifest a mortality rate that is substantially higher than that observed among adequately exercising patients, but comparable to that observed among very poorly exercising patients. This elevated risk underscores an important challenge for managing patients undergoing pharmacological stress testing

Warranty period of normal stress myocardial perfusion imaging in diabetic patients: A propensity score analysis

Background: We evaluated the relationship between diabetes and temporal characteristics of cardiac risk at long-term follow-up in a propensity score-matched cohort of diabetic and non-diabetic patients with normal stress myocardial perfusion single-photon emission computed tomography (MPS). Methods and Results: We studied 828 consecutive patients with suspected or known coronary artery disease and normal perfusion at stress MPS. To account for differences in baseline characteristics between diabetics and non-diabetics, we created a propensity score-matched cohort considering clinical variables and stress type. After matching, clinical characteristics were comparable in 260 diabetic and 260 non-diabetic patients. All patients were followed for at least 1 year (median 53 months). End-point events were cardiac death or nonfatal myocardial infarction. At Cox analysis, diabetes (hazard ratio 3.9, P <.01) and post-stress left ventricular ejection fraction (LVEF) (less-than or equal to)45% (hazard ratio 4.1, P <.01) were independent predictors of events. At parametric analysis, non-diabetic patients with post-stress LVEF >45% remained at low risk for the entire length of follow-up, while the highest probability of events and the major risk acceleration was observed in patients with diabetes and post-stress LVEF (less-than or equal to)45%. Conclusions: After a normal stress MPS, diabetic patients are at higher risk for cardiac events than non-diabetic subjects also after balancing clinical characteristics and stress type by propensity score analysis. The warranty period of a normal stress MPS varies according to diabetic status and post-stress LVEF. (copyright) 2013 American Society of Nuclear Cardiology

Conversion of birch bark to biofuels

status: publishe

Chronotropic response to vasodilator-stress in patients submitted to myocardial perfusion imaging: impact on the accuracy in detecting coronary stenosis

Aims: A lower heart rate response (HRR) during vasodilator MPI has been shown to have a relevant adverse prognostic impact. We sought to evaluate the interaction among individual HRR to vasodilator stress and myocardial perfusion imaging (MPI) accuracy in patients with suspected ischemic heart disease (IHD). Methods and results: One hundred and sixty-five consecutive patients were submitted to vasodilator-stress MPI on a cardiac camera equipped with cadmium-zinc-thelluride detectors and coronary angiography. A coronary stenosis >70 % was considered significant. In every patient, the summed difference score (SDS) was computed from MPI images. Patients were categorized according to the tertiles of the distribution of individual HRR during dipyridamole: “Group 1” (HRR 12 bpm; highest tertile). Significant coronary artery disease (CAD) was present in 102 (62 %) patients. In the overall population, MPI showed a significant accuracy (AUC: 0.81, 95 % CI 0.74–0.86; p < 0.001) in unmasking the presence of significant coronary stenosis. Interestingly, in patients with a blunted HRR during dipyridamole (“Group 1”) MPI showed a significantly lower sensitivity (68 %) in detecting CAD than in those with a higher HRR (“Group 3”) (91 %, p = 0.007), despite a preserved specificity (76 % vs 77 %, P=NS). Similarly, the correlation among CAD extent and post-stress LV functional stunning was limited to “Group 3” patients, while it disappeared in those with blunted HRR. Conclusions: In patients with suspected IHD, MPI sensitivity is strongly influenced by the magnitude of patient heart rate increase to the pharmacologic stressor, suggesting an interaction among blunted HRR and lower accuracy in unmasking CAD

Prognostic Value of Stress Myocardial Perfusion Imaging in Asymptomatic Diabetic Patients

Although there has been a marked decline in mortality due to coronary artery disease (CAD) in the overall population in the past three decades, reducing CAD mortality in patients with diabetes has proven exceptionally difficult. Several epidemiological studies have shown that diabetes is associated with a marked increase in the risk of CAD. The symptoms are not a reliable means of identifying patients at higher risk considering that angina is threefold less common in diabetics than in nondiabetics. The increasing prevalence of diabetes and the associated high cardiac risk raised the question as to the need to develop approaches to identify the diabetic patients at the highest risk of CAD. Stress myocardial perfusion single-photon emission computed tomography has taken a central role in the diagnosis, evaluation, and management of CAD in diabetic patients. This review focuses on the prognostic value of cardiac radionuclide imaging in asymptomatic diabetic patients. {\textcopyright} 2014 Springer Science+Business Media New York